hotspot -WSS

hotspot

author：entertainment 2025-08-11 08:00:38 - browse：7991

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： ‘The Bear’ and hospitality in hospitals

explore

Wikipedia

WSS

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

In venture capital firm's success, lessons for turning crisis into profit

Harvard scientists, with Google, unveil the most detailed brain map ever

Gut bacteria may contribute to kidney autoimmunity, study finds

Sage's campaign to raise awareness of postpartum depression hits a nerve

Judge rejects Trump's counterclaim against E. Jean Carroll

leisure time

hotspot

leisure time

Medicare proposal to cover medical devices draws a mixed reaction

Four alarming medical procedures we’re glad history forgot

Hepatitis C has a cure — but many Americans still lack access to it

Study: Black kids more likely to die after surgery than white kids

Moonlake's readout produced a cash windfall. Risks remain

Florida Supreme Court upholds state's abortion ban

What does generative AI mean for health care? We asked experts

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Virginia high school admissions case could be legal follow

Gut bacteria may contribute to kidney autoimmunity, study finds

focus

An Ebola outbreak presents a new mystery involving children

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

More regulation could be coming for drug ads

Ohioans vote in high

U.K. decision on ALS drug has neurologists, advocates up in arms

Germany receives 178 compensation applications from gay servicepeople over discrimination

focus

explore

Wikipedia

entertainment